PRCT
Price
$23.34Alerts
Change
+$0.29 (+1.26%)
Updated
Nov 11 closing price
Capitalization
1.18B
110 days until earnings call
Intraday BUY SELL Signals
RDNT
Price
$78.08Alerts
Change
+$0.14 (+0.18%)
Updated
Nov 11 closing price
Capitalization
5.98B
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRCT vs RDNT

PRCT vs RDNT Comparison Chart in %
View a ticker or compare two or three
VS
PRCT vs. RDNT commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRCT is a Hold and RDNT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PRCT with price predictions
Nov 11, 2026

PRCT in upward trend: 10-day moving average moved above 50-day moving average on October 30, 2026

The 10-day moving average for PRCT crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on PRCT as a result. In 75 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for PRCT just turned positive on October 08, 2026. Looking at past instances where PRCT's MACD turned positive, the stock continued to rise in 36 of 45 cases over the following month. The odds of a continued upward trend are 80%.

PRCT moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRCT advanced for three days, in 195 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 148 of 178 cases where PRCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

PRCT broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.473) is normal, around the industry mean (4.142). P/E Ratio (-10.574) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.249) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PRCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for RDNT with price predictions
Nov 11, 2026

Aroon Indicator for RDNT shows an upward move is likely

RDNT's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator showed a similar pattern. In 181 of the 210 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on RDNT as a result. In 64 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.

RDNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RDNT crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 230 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for RDNT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 29 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

RDNT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.457) is normal, around the industry mean (67.298). RDNT's P/E Ratio (-292.308) is considerably lower than the industry average of (4.239). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
RDNT: Fundamental Ratings
RDNT
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
37
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRCTRDNT
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (PRCT: $23.05 vs. RDNT: $77.94)
Brand notoriety: PRCT and RDNT are both not notable
PRCT represents the Medical/Nursing Services, while RDNT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PRCT: 143% vs. RDNT: 75%
Market capitalization -- PRCT: $1.18B vs. RDNT: $5.98B
PRCT [@Medical/Nursing Services] is valued at $1.18B. RDNT’s [@Medical Specialties] market capitalization is $5.98B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRCT’s FA Score shows that 1 FA rating(s) are green while RDNT’s FA Score has 1 green FA rating(s).

  • PRCT’s FA Score: 1 green, 4 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than PRCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRCT’s TA Score shows that 6 TA indicator(s) are bullish while RDNT’s TA Score has 6 bullish TA indicator(s).

  • PRCT’s TA Score: 6 bullish, 3 bearish.
  • RDNT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRCT is a better buy in the short-term than RDNT.

Price Growth

PRCT (@Medical/Nursing Services) experienced а +14.28% price change this week, while RDNT (@Medical Specialties) price change was +6.50% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.

Reported Earning Dates

PRCT is expected to report earnings on Mar 02, 2027.

RDNT is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-4.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

PRCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRCT has been loosely correlated with DCTH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRCT jumps, then DCTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRCT
1D Price
Change %
PRCT100%
+1.26%
DCTH - PRCT
38%
Loosely correlated
+8.31%
TWST - PRCT
37%
Loosely correlated
-7.22%
ZBH - PRCT
36%
Loosely correlated
+0.14%
RDNT - PRCT
35%
Loosely correlated
+0.18%
NTRA - PRCT
35%
Loosely correlated
+2.51%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
+0.18%
ITGR - RDNT
49%
Loosely correlated
+0.05%
GKOS - RDNT
48%
Loosely correlated
+4.64%
NNOX - RDNT
46%
Loosely correlated
-2.52%
ICUI - RDNT
43%
Loosely correlated
-2.11%
CERS - RDNT
42%
Loosely correlated
+8.72%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRCY88.334.75
+5.68%
Mercury Systems
AKTX7.450.32
+4.49%
Akari Therapeutics Plc
RR0.950.04
+4.30%
Richtech Robotics
ABEV2.800.03
+1.08%
Ambev SA
RJET21.34-0.08
-0.37%
Republic Airways Holdings Inc.